← Leaderboards
Justin L. Mott
Mayo Clinic Rochester
$4,114,486
Attributed
$4,114,486
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $572.7K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,114,486 · 5
By mechanism
R01$1,722,761 · 1
P20$1,131,302 · 1
K01$730,682 · 1
T32$381,240 · 1
R03$148,501 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Andrew D Badley$16,248,519
- Cornelia M Weyand$30,789,284
- Davide Povero$161,400
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCell DeathPathway InteractionsProteinsCellsCholangiocyteBile DuctCholangiocarcinomaMicrornasMalignant NeoplasmsTumorLeadRegulationBasePreventCessation Of LifeSignal TransductionMutationResistanceInflammationMitochondriaProtein ExpressionBinding (Molecular Function)Chemotherapy
Grant awards (21)
Medical Scientist Training Program at the University of Nebraska$251,972
T32 · FY2025 · GM · contact PI
Medical Scientist Training Program at the University of Nebraska$129,268
T32 · FY2024 · GM · contact PI
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma$341,335
R01 · FY2022 · CA · contact PI
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma$348,301
R01 · FY2021 · CA · contact PI
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma$348,301
R01 · FY2020 · CA · contact PI
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma$337,851
R01 · FY2019 · CA · contact PI
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma$346,973
R01 · FY2018 · CA · contact PI
Palmitoleate Protects against Cholangiocyte Lipoapoptosis$225,750
P20 · FY2018 · GM · contact PI
Palmitoleate Protects against Cholangiocyte Lipoapoptosis$225,750
P20 · FY2017 · GM · contact PI
Palmitoleate Protects against Cholangiocyte Lipoapoptosis$225,750
P20 · FY2016 · GM · contact PI
Palmitoleate Protects against Cholangiocyte Lipoapoptosis$215,552
P20 · FY2015 · GM · contact PI
Palmitoleate Protects against Cholangiocyte Lipoapoptosis$238,500
P20 · FY2014 · GM · contact PI
Apoptosis Effectors Targeted By Hedgehog-Supported MicroRNAs$74,250
R03 · FY2012 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$132,268
K01 · FY2011 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$132,268
K01 · FY2011 · DK · contact PI
Apoptosis Effectors Targeted By Hedgehog-Supported MicroRNAs$74,250
R03 · FY2011 · DK · contact PI
Apoptosis Effectors Targeted By Hedgehog-Supported MicroRNAs$1
R03 · FY2011 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$129,201
K01 · FY2010 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$126,225
K01 · FY2009 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$121,499
K01 · FY2008 · DK · contact PI
Cholangiocyte microRNAs Regulate Mcl-1 and Cell Death$89,221
K01 · FY2007 · DK · contact PI